Also trades as: INDV.L (LSE) · $vol 5M
INDV NASDAQ
Indivior Pharmaceuticals Inc
1W: +2.3%
1M: -3.0%
3M: +20.5%
YTD: +12.0%
1Y: +138.1%
3Y: +66.8%
5Y: +277.6%
$40.99
+0.96 (+2.40%)
Weekly Expected Move ±3.5%
$38
$39
$41
$42
$43
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.1B
52W Range16.99-42.81
Volume1,231,138
Avg Volume2,023,024
Beta1.15
Dividend$0.64
Analyst Ratings
Company Info
CEOJoseph J. Ciaffoni
Employees838
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2014-12-29
Websiteindivior.com
10710 Midlothian Turnpike
North Chesterfield, VA 23235
US
North Chesterfield, VA 23235
US
804 379 1090
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Latest News
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable
Bull of the Day: Neurocrine Biosciences (NBIX)
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Heidbreder Christian | S-Sale | 18,586 | $41.14 | 2026-07-10 |
| Ciaffoni Joseph | M-Exempt | 1,266,903 | — | 2026-06-22 |
| Ciaffoni Joseph | F-InKind | 612,549 | $38.32 | 2026-06-22 |
| Ciaffoni Joseph | M-Exempt | 1,266,903 | — | 2026-06-22 |
| Heidbreder Christian | S-Sale | 18,586 | $38.06 | 2026-06-11 |